node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
AADAC | FMO3 | ENSCPOP00000003748 | ENSCPOP00000029013 | Arylacetamide deacetylase. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.583 |
AADAC | FMO4 | ENSCPOP00000003748 | ENSCPOP00000024809 | Arylacetamide deacetylase. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.583 |
AADAC | Fmo5 | ENSCPOP00000003748 | ENSCPOP00000012498 | Arylacetamide deacetylase. | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | 0.583 |
AADACL3 | FMO3 | ENSCPOP00000000201 | ENSCPOP00000029013 | Arylacetamide deacetylase like 3. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.583 |
AADACL3 | FMO4 | ENSCPOP00000000201 | ENSCPOP00000024809 | Arylacetamide deacetylase like 3. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.583 |
AADACL3 | Fmo5 | ENSCPOP00000000201 | ENSCPOP00000012498 | Arylacetamide deacetylase like 3. | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | 0.583 |
AFMID | FMO3 | ENSCPOP00000014887 | ENSCPOP00000029013 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.594 |
AFMID | FMO4 | ENSCPOP00000014887 | ENSCPOP00000024809 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.594 |
AFMID | Fmo5 | ENSCPOP00000014887 | ENSCPOP00000012498 | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | 0.594 |
Aadacl4 | FMO3 | ENSCPOP00000009193 | ENSCPOP00000029013 | Uncharacterized protein. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.583 |
Aadacl4 | FMO4 | ENSCPOP00000009193 | ENSCPOP00000024809 | Uncharacterized protein. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.583 |
Aadacl4 | Fmo5 | ENSCPOP00000009193 | ENSCPOP00000012498 | Uncharacterized protein. | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | 0.583 |
COQ3 | FMO3 | ENSCPOP00000005128 | ENSCPOP00000029013 | Ubiquinone biosynthesis O-methyltransferase, mitochondrial; O-methyltransferase that catalyzes the 2 O-methylation steps in the ubiquinone biosynthetic pathway; Belongs to the class I-like SAM-binding methyltransferase superfamily. UbiG/COQ3 family. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.606 |
COQ3 | FMO4 | ENSCPOP00000005128 | ENSCPOP00000024809 | Ubiquinone biosynthesis O-methyltransferase, mitochondrial; O-methyltransferase that catalyzes the 2 O-methylation steps in the ubiquinone biosynthetic pathway; Belongs to the class I-like SAM-binding methyltransferase superfamily. UbiG/COQ3 family. | Dimethylaniline monooxygenase [N-oxide-forming]. | 0.606 |
COQ3 | Fmo5 | ENSCPOP00000005128 | ENSCPOP00000012498 | Ubiquinone biosynthesis O-methyltransferase, mitochondrial; O-methyltransferase that catalyzes the 2 O-methylation steps in the ubiquinone biosynthetic pathway; Belongs to the class I-like SAM-binding methyltransferase superfamily. UbiG/COQ3 family. | Dimethylaniline monooxygenase [N-oxide-forming] 5; In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme. | 0.606 |
COQ3 | LOC100716044 | ENSCPOP00000005128 | ENSCPOP00000008690 | Ubiquinone biosynthesis O-methyltransferase, mitochondrial; O-methyltransferase that catalyzes the 2 O-methylation steps in the ubiquinone biosynthetic pathway; Belongs to the class I-like SAM-binding methyltransferase superfamily. UbiG/COQ3 family. | Cytochrome P450 2C-like protein; Belongs to the cytochrome P450 family. | 0.527 |
FMO3 | AADAC | ENSCPOP00000029013 | ENSCPOP00000003748 | Dimethylaniline monooxygenase [N-oxide-forming]. | Arylacetamide deacetylase. | 0.583 |
FMO3 | AADACL3 | ENSCPOP00000029013 | ENSCPOP00000000201 | Dimethylaniline monooxygenase [N-oxide-forming]. | Arylacetamide deacetylase like 3. | 0.583 |
FMO3 | AFMID | ENSCPOP00000029013 | ENSCPOP00000014887 | Dimethylaniline monooxygenase [N-oxide-forming]. | Kynurenine formamidase; Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. | 0.594 |
FMO3 | Aadacl4 | ENSCPOP00000029013 | ENSCPOP00000009193 | Dimethylaniline monooxygenase [N-oxide-forming]. | Uncharacterized protein. | 0.583 |